Long-term Risk of Second Primary Malignancies for Chronic Myeloid Leukaemia in the French Imatinib-based SPIRIT Trial
Clinical trial NCT06646978 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06646978
- Sponsor
- Poitiers University Hospital
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2024-05-01
- Primary completion
- 2025-05-01
- Enrollment
- 787
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.